GL1X · GenesisL1 explorer

Research workbench

Structure of human parg complexed with parg-002

Analyse Structure of human parg complexed with parg-002 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7KG1
Type
protein
Length
501 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
POLY(ADP-ribose) glycohydrolase
EC
3.2.1.143
UniProt
Q86W56
Ligands
WDD, SO4
Pockets
5 · best druggability 0.65

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APOLY(ADP-ribose) glycohydrolase (EC 3.2.1.143)protein50140% helix, 14% strandQ86W56

Ligands and binding sites

  • WDD · 1,3-dimethyl-8-{[2-(morpholin-4-yl)ethyl]amino}-3,7-dihydro-1H-purine-2,6-dione · ligand · chains A
  • SO4 · Sulfate ion · ion · 5 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · 4 copies · chains A
  • GOL · Glycerol · additive · 2 copies · chains A
  • CAC · Cacodylate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13960.650.7940SO4
21840.550.7930WDD, GOL, SO4
3620.380.8020empty
4850.380.7612empty
5900.370.7623DMS

Modifications

Observed in the structure: 1 modified (artifact).

Compared structures

  • 7KG1 · Structure of human PARG complexed with PARG-002 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q86W56 · AlphaFold monomer V2.0 prediction for POLY(ADP-ribose) glycohydrolase (Q86W56) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.